Spago Nanomedical AB (publ)

kr 0.04As of Sun 8 Nov 2026, 12:00 UTC
STO:SPAGOHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (41.15%)
Div yield —
ROE (142.15%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM (74.47%)
Mkt cap kr 28.74M
ROIC (88.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.0423
17.45%
(39.49%)
Hold 6|8|4|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
9.30%
21.89%
20.28%
12.78%
Revenuekr M
3.302
3.214
3.120
3.137
6.13%
1.58%
(1.07%)
(4.48%)
Peers (US$2.906M)
Cap (US$)
PE
3.597M
—
Capital
TTM
5Y
10Y
Leveragex
3.730
0.298
0.244
EBIT/Intx
0.867
0.378
0.440
Own earn%
(811.13)
96.58
84.19
Sh yield%
46.25
28.51
28.36
Owners
Insiders/Inst%
13.83
45.87
Short interest%
2.91
SBC / revenue%
5.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
3–10
$1 testx
0.4
Incr. ROIC%
1